The amino acid, L-arogenate, is widely utilized by both microorganisms and higher plants as a precursor of L-phenylalanine and L-tyrosine. It is of increasing importance in both basic university-sponsored research and in applied research within industry to have access to L-arogenate as substrate for a number of newly described enzymes, for use in various nutritional and physiological experiments, for use as authentic standards, and for use as starting material in the making of derivative compounds. Because of the placement of the compound within diverse patterns of aromatic-amino-acid pathway construction and regulation, derivatives of L-arogenate have potential for design of antimicrobial and herbicidal compounds. L-Arogenate is currently produced at great expense (greater than $10 per mg) as a minor accumulation entity in Neurospora crassa, in an initial preparation heavily contaminated with other cyclohexadienyl compounds produced from prephenate. A strategy is proposed for the genetic engineering of Brevibacterium flavum to obtain high-quality yields of L-arogenate applicable to commercial production.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AI031753-02
Application #
3506193
Study Section
Special Emphasis Panel (SSS (B4))
Project Start
1991-09-01
Project End
1994-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Metagene Corporation
Department
Type
DUNS #
City
Alachua
State
FL
Country
United States
Zip Code
32615